Rockwell Medical (RMTI) Current Deferred Revenue (2010 - 2024)
Rockwell Medical (RMTI) posted Current Deferred Revenue of $46000.0 for Q4 2024, down 90.55% on a QoQ basis from $487000.0 in Q3 2024, and little changed year-over-year from $46000.0 in Q1 2024.
Rockwell Medical (RMTI) Current Deferred Revenue (2010 - 2024) Analysis & Trends
Rockwell Medical's Current Deferred Revenue history runs 15 years deep, the most recent figure standing at $46000.0 for Q4 2024.
- Quarterly Current Deferred Revenue changed 0.0% year-over-year to $46000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $46000.0 (changed 0.0% YoY) and the FY2024 annual result came in at $46000.0, changed 0.0% from the prior year.
- Current Deferred Revenue was $46000.0 for Q4 2024 at Rockwell Medical, down from $487000.0 in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $11.6 million in Q1 2020 and bottomed at $46000.0 in Q4 2023.
- A 5-year average of $2.6 million and a median of $2.2 million in 2021 frame the typical range for Current Deferred Revenue.
- Annual changes were most pronounced in 2022 — Current Deferred Revenue surged 1346.0% — and 2023, when it sank 98.94%.
- Rockwell Medical's Current Deferred Revenue stood at $2.2 million in 2020, then soared by 275.03% to $8.2 million in 2021, then slumped by 46.9% to $4.3 million in 2022, then sank by 98.94% to $46000.0 in 2023, then changed by 0.0% to $46000.0 in 2024.
- Business Quant data shows RMTI's Current Deferred Revenue at $46000.0 in Q4 2024, $487000.0 in Q3 2024, and $46000.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Rockwell Medical | 25.77 Mn | 1.88 Mn | 2.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 46,000.00 |
| Sep 30, 2024 | 487,000.00 |
| Jun 30, 2024 | 46,000.00 |
| Mar 31, 2024 | 510,000.00 |
| Dec 31, 2023 | 46,000.00 |
| Sep 30, 2023 | 533,000.00 |
| Jun 30, 2023 | 2.73 Mn |
| Mar 31, 2023 | 259,000.00 |
| Dec 31, 2022 | 4.33 Mn |
| Sep 30, 2022 | 2.16 Mn |
| Jun 30, 2022 | 2.17 Mn |
| Mar 31, 2022 | 7.62 Mn |
| Dec 31, 2021 | 8.16 Mn |
| Sep 30, 2021 | 2.18 Mn |
| Jun 30, 2021 | 150,000.00 |
| Mar 31, 2021 | 2.17 Mn |
| Dec 31, 2020 | 2.18 Mn |
| Sep 30, 2020 | 2.18 Mn |
| Jun 30, 2020 | 2.17 Mn |
| Mar 31, 2020 | 11.63 Mn |